264 related articles for article (PubMed ID: 7624362)
1. A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity.
Mack M; Riethmüller G; Kufer P
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):7021-5. PubMed ID: 7624362
[TBL] [Abstract][Full Text] [Related]
2. Construction and biological activity of a recombinant bispecific single-chain antibody designed for therapy of minimal residual colorectal cancer.
Kufer P; Mack M; Gruber R; Lutterbüse R; Zettl F; Riethmüller G
Cancer Immunol Immunother; 1997; 45(3-4):193-7. PubMed ID: 9435872
[TBL] [Abstract][Full Text] [Related]
3. A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes.
Löffler A; Kufer P; Lutterbüse R; Zettl F; Daniel PT; Schwenkenbecher JM; Riethmüller G; Dörken B; Bargou RC
Blood; 2000 Mar; 95(6):2098-103. PubMed ID: 10706880
[TBL] [Abstract][Full Text] [Related]
4. Efficient construction of a diabody using a refolding system: anti-carcinoembryonic antigen recombinant antibody fragment.
Asano R; Kudo T; Nishimura Y; Makabe K; Hayashi H; Suzuki M; Tsumoto K; Kumagai I
J Biochem; 2002 Dec; 132(6):903-9. PubMed ID: 12473192
[TBL] [Abstract][Full Text] [Related]
5. Biologic properties of a bispecific single-chain antibody directed against 17-1A (EpCAM) and CD3: tumor cell-dependent T cell stimulation and cytotoxic activity.
Mack M; Gruber R; Schmidt S; Riethmüller G; Kufer P
J Immunol; 1997 Apr; 158(8):3965-70. PubMed ID: 9103467
[TBL] [Abstract][Full Text] [Related]
6. [Biologic activity of bispecific single chain antibody against human gamma-seminoprotein and CD3 molecule].
Wang D; Wang H; Wu GJ; Wu WZ; Yang SL; Lin WH; Tan JM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):500-3. PubMed ID: 16806016
[TBL] [Abstract][Full Text] [Related]
7. Bispecific CD3 x CD19 diabody for T cell-mediated lysis of malignant human B cells.
Kipriyanov SM; Moldenhauer G; Strauss G; Little M
Int J Cancer; 1998 Aug; 77(5):763-72. PubMed ID: 9688311
[TBL] [Abstract][Full Text] [Related]
8. "Diabodies": small bivalent and bispecific antibody fragments.
Holliger P; Prospero T; Winter G
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6444-8. PubMed ID: 8341653
[TBL] [Abstract][Full Text] [Related]
9. Bispecific tandem diabody for tumor therapy with improved antigen binding and pharmacokinetics.
Kipriyanov SM; Moldenhauer G; Schuhmacher J; Cochlovius B; Von der Lieth CW; Matys ER; Little M
J Mol Biol; 1999 Oct; 293(1):41-56. PubMed ID: 10512714
[TBL] [Abstract][Full Text] [Related]
10. [Construction and characterization of bispecific single-chain antibody fragments SZ-2/SZ-21 against platelet glycoprotein Ib alpha and beta3].
Dai K; An G; Ruan C
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1493-7. PubMed ID: 12509914
[TBL] [Abstract][Full Text] [Related]
11. Construction, expression and tumor targeting of a single-chain Fv against human colorectal carcinoma.
Fang J; Jin HB; Song JD
World J Gastroenterol; 2003 Apr; 9(4):726-30. PubMed ID: 12679920
[TBL] [Abstract][Full Text] [Related]
12. Effect of domain order on the activity of bacterially produced bispecific single-chain Fv antibodies.
Kipriyanov SM; Moldenhauer G; Braunagel M; Reusch U; Cochlovius B; Le Gall F; Kouprianova OA; Von der Lieth CW; Little M
J Mol Biol; 2003 Jun; 330(1):99-111. PubMed ID: 12818205
[TBL] [Abstract][Full Text] [Related]
13. Production of functionalized single-chain Fv antibody fragments binding to the ED-B domain of the B-isoform of fibronectin in Pichia pastoris.
Marty C; Scheidegger P; Ballmer-Hofer K; Klemenz R; Schwendener RA
Protein Expr Purif; 2001 Feb; 21(1):156-64. PubMed ID: 11162401
[TBL] [Abstract][Full Text] [Related]
14. Production and characterization of bispecific single-chain antibody fragments.
De Jonge J; Brissinck J; Heirman C; Demanet C; Leo O; Moser M; Thielemans K
Mol Immunol; 1995 Dec; 32(17-18):1405-12. PubMed ID: 8643110
[TBL] [Abstract][Full Text] [Related]
15. T-cell activation and cytokine production via a bispecific single-chain antibody fragment targeted to blood-stage malaria parasites.
Yoshida S; Kobayashi T; Matsuoka H; Seki C; Gosnell WL; Chang SP; Ishii A
Blood; 2003 Mar; 101(6):2300-6. PubMed ID: 12411309
[TBL] [Abstract][Full Text] [Related]
16. Construction and characterization of a bispecific diabody for retargeting T cells to human carcinomas.
Helfrich W; Kroesen BJ; Roovers RC; Westers L; Molema G; Hoogenboom HR; de Leij L
Int J Cancer; 1998 Apr; 76(2):232-9. PubMed ID: 9537586
[TBL] [Abstract][Full Text] [Related]
17. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
Wang Y; Li X; Chen W
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
[TBL] [Abstract][Full Text] [Related]
18. Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105).
Nettelbeck DM; Miller DW; Jérôme V; Zuzarte M; Watkins SJ; Hawkins RE; Müller R; Kontermann RE
Mol Ther; 2001 Jun; 3(6):882-91. PubMed ID: 11407902
[TBL] [Abstract][Full Text] [Related]
19. [Cloning and expression of single chain Fv gene against human colorectal carcinoma].
Fang J; Song JD
Ai Zheng; 2002 Jul; 21(7):740-4. PubMed ID: 12479098
[TBL] [Abstract][Full Text] [Related]
20. A dimeric bispecific miniantibody combines two specificities with avidity.
Müller KM; Arndt KM; Plückthun A
FEBS Lett; 1998 Jul; 432(1-2):45-9. PubMed ID: 9710248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
